NCT02769962 2025-07-28
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Xuzhou Central Hospital
Singapore General Hospital
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Candiolo Cancer Institute - IRCCS
Cancer Prevention and Research Institute, Italy
Taichung Veterans General Hospital